Ronald Menezes
Net Worth

Last updated:

What is Ronald Menezes net worth?

The estimated net worth of Mr. Ronald Menezes is at least $3,045,124 as of 10 Nov 2021. He has earned $445,084 from insider trading and has received compensation worth at least $2,600,040 in Sientra, Inc..

What is the salary of Ronald Menezes?

Mr. Ronald Menezes salary is $650,010 per year as Pres, Chief Executive Officer & Director in Sientra, Inc..

How old is Ronald Menezes?

Mr. Ronald Menezes is 63 years old, born in 1962.

What stocks does Ronald Menezes currently own?

As insider, Mr. Ronald Menezes owns shares in one company:

Company Title Shares Price per share Total value
Sientra, Inc. (SIEN) Pres, Chief Executive Officer & Director 427,302 $0 $0

What does Sientra, Inc. do?

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Ronald Menezes insider trading

Sientra, Inc.

Mr. Ronald Menezes has made only one insider trade in 2021, according to the Form 4 filled with the SEC. He sold 78,498 units of SIEN stock worth $445,084 on 10 Nov 2021.

As of 10 Nov 2021 he still owns at least 427,302 units of SIEN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 78,498 $5.67 $445,084
Purchase
Common Stock 5,800 $6.98 $40,484

Sientra key executives

Sientra, Inc. executives and other stock owners filed with the SEC: